Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAdvanced Oncotherapy Share News (AVO)

  • This share is currently suspended. It was suspended at a price of 1.925

Share Price Information for Advanced Oncotherapy (AVO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.925
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1.925
AVO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Jadestone Energy holds production and capex targets

Fri, 30th Jun 2023 19:54

(Alliance News) - The following is a round-up of updates by London-listed companies, issued Friday and not separately reported by Alliance News:

----------

Essentially Group PLC - UAE-based health food company - Announces a summary of final results for its operating company, Essentially Juices manufacturing LLC for the year ended December 31 2022. Chief Executive Raja Wail Abuljebain says results "demonstrate our ability to capitalize on the UAE's thriving consumer economy and the increasing demand for nutritious juices and snacks." Revenue rose to AED4.7 million from AED3.3 million while pre-tax loss widened to AED2.0 million from AED1.3 million.

----------

Jadestone Energy PLC - oil and gas production company focused on Asia-Pacific region - Reaffirms 2023 group production, underlying operating cost and capital expenditure guidance. Says the Akatara gas development project in Indonesia remains on plan, budget and schedule for first gas in the first half of 2024. Intends to create role of chief operating officer.

----------

JPMorgan Global Core Real Assets Ltd - London, England-based trust - Says net asset value per share rose to 102.0 pence in the year to February 28 from 95p the year prior. Declared total dividend of 4.05p up from 4p.

----------

Advanced Oncotherapy PLC - London-based particle therapy for cancer treatment company - Updates on financing discussions. Reports talks with a new lender regarding a GBP8 million provision of extra funding. However, prospective lender needs more time, between three and six months, to commit to such a facility. As such, company no believes this to be a viable option. Adds no other financing options have been successful yet. As a result, company is in a "highly constrained financial position and requires additional financing urgently in order to continue as a going concern." Requests suspension of shares pending clarification of its financial position.

----------

Geiger Counter Ltd - Jersey-based investor in uranium exploration and production stocks - Reports net asset value fell to 41.27 pence at March 31 from 47.46p at September 30, 2022. Adds NAV at time of writing report was 43.03p. Remains confident over the long-term outlook for uranium. "Expected demand for uranium is higher than the available supply and with such structural impetus, we believe the outlook for nuclear energy is bright," company says.

----------

Inspired PLC - Preston, England-based energy advisory and sustainability services provider - Reports all resolutions at the annual general meeting today were passed. This includes the proposed share consolidation.

----------

ThomasLloyd Energy Impact Trust PLC - London-based renewable energy investment trust - Announces that at the annual general meeting held today, resolutions 1-4 were duly passed. Notes 35% of shareholders withheld votes on resolutions 5 (continuation of the company), 6 (authority to buy back shares) and 7 (consent to shorter notice of general meetings). Meeting was adjourned and votes will be put to further meeting after publication of the 2022 annual report and audited financial statements. Chair Sue Inglis, says: "Due to the uncertainty surrounding the Company's financial position, which has arisen principally as a result of its Indian construction project, the AGM was adjourned ahead of the continuation vote."

----------

By Jeremy Cutler, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
2 Apr 2024 17:35

TRADING UPDATES: Sareum ups retail offer; SThree nabs former ITV exec

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
29 Feb 2024 18:52

EARNINGS AND TRADING: Frontier IP sells last of Exscientia holding

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
2 Feb 2024 14:06

IN BRIEF: Advanced Oncotherapy eyes USD15 million tranche in February

Advanced Oncotherapy PLC - London-based provider of proton therapy for cancer treatment - Regarding its recapitalisation plan, company works alongside investor towards initial tranche of funding, which it expects to be about USD15 million to be received this month. However, it adds that there can be no guarantee that this funding will be received, nor that it will be received on time. Further, Advanced Oncotherapy says it remains in advanced talks with a third-party investor regarding a short-term loan facility which would provide the company with additional short term bridge financing.

Read more
9 Jan 2024 14:06

IN BRIEF: Advanced Oncotherapy in advanced talks regarding loan

Advanced Oncotherapy PLC - London-based provider of proton therapy for cancer treatment - Continues to work on its recapitalisation plan with an unnamed third party investor. Says discussions are at an advanced stage but has not entered into any binding agreements with the investor, nor received any funds. This comes after it signed a non-binding term sheet with the investor in October. The investor is expected to provide funding of up to USD80 million to meet the company's cashflow requirements through to the European certification of the LIGHT System. Notes the treatment of first patients with LIGHT is now targeted for 2024 with certification of the LIGHT System to follow thereafter. Anticipates the financing to be a mixture of equity and debt financing. The firm currently owes GBP28 million to trade and other unsecured creditors and GBP41 million of financial debt.

Read more
23 Oct 2023 18:51

IN BRIEF: Advanced Oncotherapy in talks over possible cash injection

Advanced Oncotherapy PLC - London-based provider of proton therapy for cancer treatment - Updates on financing discussions and current financial position. Signs non-binding term sheet with a third-party investor. Investor is expected to provide funding of up to USD80 million to meet the company's cashflow requirements through to the European certification of the LIGHT System. Notes the treatment of first patients with LIGHT is now targeted for 2024 with certification of the LIGHT System to follow thereafter. Anticipates the financing to be a mixture of equity and debt financing.

Read more
3 Oct 2023 18:29

IN BRIEF: Advanced Oncotherapy results delayed, funding talks continue

Advanced Oncotherapy PLC - London-based provider of proton therapy for cancer treatment - On Friday, says it is not in a position to publish its accounts for the year ended December 31, 2022, and the unaudited interim results for the six months ended June 30, together with the 2022 annual report. Explains the 2023 interim results are contingent on the finalisation and publication of the 2022 annual report.

Read more
17 Jul 2023 21:41

Advanced Oncotherapy plans to raise up to GBP110 million

(Alliance News) - Advanced Oncotherapy PLC on Monday announced a prospective recapitalisation and funding plan to raise up to GBP110 million.

Read more
2 Jun 2023 19:37

IN BRIEF: Advanced Oncotherapy optimistic of securing further funding

Advanced Oncotherapy PLC - London-based particle therapy for cancer treatment company - Announces it has received a conversion notice for a portion of the convertible notes, which were issued to a French counterparty, as announced March 1 into new shares in the company. Says 10 convertible notes have been converted worth GBP50,000 at a conversion price of GBP0.25. Company also pays GBP56,702 conversion fee as the conversion price is below the nominal value of the shares. States this will be settled through the issuance of 756,020 new shares. Further, says in talks to raise further funding under the secured loan note agreement as well as through other non-dilutive financing options and is hopeful of securing additional financing during June 2023. Optimistic of a satisfactory outcome on the financing options being explored. In addition, company says it has issued convertible notes totalling GBP34,600 under its secured convertible loan note agreement.

Read more
15 May 2023 21:10

TRADING UPDATES: Online Blockchain keeping ADVFN at "arms length"

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
18 Apr 2023 10:38

Advanced Oncotherapy considers US sale of business to secure funding

(Alliance News) - Advanced Oncotherapy PLC on Tuesday said it is continuing to consider funding options to allow it to complete its first Light machine and begin treating patients later this year.

Read more
20 Mar 2023 13:06

IN BRIEF: Advanced Oncotherapy receives GBP1.2 million in funds

Advanced Oncotherapy PLC - London-based particle therapy for cancer treatment - Receives balance of funds, about GBP1.2 million, due under the secured convertible loan agreements entered into by the company with investors and directors. The balance of funds that have been received by the company includes GBP500,000 that was due to be received from Executive Chair Michael Sinclair by mid-March 2023. Currently, GBP5.0 million has been received from investors under the secured convertible loan note. Says it is also taking steps to raise additional financing.

Read more
1 Mar 2023 21:15

TRADING UPDATES: Galantas to raise GBP1.2 million in private placement

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
18 Jan 2023 21:58

TRADING UPDATES: Bankers net assets drop; Invinity Energy wins funds

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
30 Dec 2022 14:33

IN BRIEF: Advanced Oncotherapy non-exec director buys 500,000 shares

Advanced Oncotherapy PLC - London-based particle therapy for cancer treatment - Non-Executive Director Michael Bradfield buys 500,000 shares at 13.17 pence, worth GBP65,825, on Thursday. Now has 8.4 million shares, a 1.6% stake.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.